Feature Channels: AIDS and HIV

Filters close
Released: 1-Jun-2020 8:05 AM EDT
COVID-19 in People Living with HIV
Rutgers University-New Brunswick

Rutgers expert explains why COVID-19 pandemic poses additional difficulties, risks to people with HIV

Newswise:Video Embedded covid-19-a-wake-up-call-for-the-need-for-new-antiviral-weapons
VIDEO
Released: 26-May-2020 3:00 PM EDT
COVID-19: A wake-up call for the need for new antiviral weapons
Morgridge Institute for Research

Even after heroic medical and societal efforts finally break the back of the current COVID-19 pandemic, the global sigh of relief may not last long. The chilling reality is that viral threats are growing more common. And they’re getting deadlier.

19-May-2020 1:45 PM EDT
Combining Multiple Measures of Alcohol Use Helps Clarify Risky Drinking in People with HIV
Research Society on Alcoholism

Researchers and clinicians can better understand the health risks facing people with HIV through comprehensive measures of alcohol use, including objective biomarkers, according to a new study in Alcoholism: Clinical and Experimental Research. Frequent or heavy alcohol use in people with HIV can affect HIV disease progression and comorbidities. Alcohol use disorder is a barrier to effectively managing HIV and contributes in multiple ways to poor health outcomes. These effects are not well understood, however, owing in part to the limitations of self-report tools (questionnaires) for measuring alcohol use. Researchers at Louisiana State University and Tulane University correlated self-reported alcohol use, measured by multiple questionnaires, with a biomarker of alcohol consumption in people with HIV. This study explores the implications of this multi-faceted approach for understanding the alcohol use of people with HIV and the related risk factors.

Released: 7-May-2020 6:30 PM EDT
Dearth of Medical Resources in Africa for COVID-19 Reminiscent of Early HIV/AIDS Pandemic
Georgetown University Medical Center

Global health scholars have issued a clarion call about the needless loss of life expected because of a foreseeable prospect of “slow and inadequate access to supplies” to control COVID-19 in sub-Saharan Africa. They say what is unfolding now is similar to when lifesaving diagnostics and treatments came to the region long after they were available elsewhere.

Newswise: Research News Tip Sheet: Story Ideas From Johns Hopkins
Released: 30-Apr-2020 8:00 AM EDT
Research News Tip Sheet: Story Ideas From Johns Hopkins
Johns Hopkins Medicine

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every Tuesday throughout the duration of the outbreak.

Newswise: New University of Kentucky study could change what we know about platelets
Released: 29-Apr-2020 9:00 AM EDT
New University of Kentucky study could change what we know about platelets
University of Kentucky

The $6.6 million study will focus on how platelets function when they form clots in blood vessels and when they sense circulating pathogens, like viruses.

Newswise: Potential new HIV treatment could mean once-a-year injection
AUDIO
Released: 27-Apr-2020 12:55 PM EDT
Potential new HIV treatment could mean once-a-year injection
University of Nebraska Medical Center (UNMC)

The advance has the potential to eliminate complications that arise from missing doses of life-saving medicines, according to the study published today in Nature Materials, a leading peer-reviewed biomedical research journal.

Released: 20-Apr-2020 3:45 PM EDT
Africa in the path of COVID-19
Columbia University, Mailman School of Public Health

In a New England Journal of Medicine "Perspective" published today, Wafaa El-Sadr, MD, MPH, global director of ICAP at Columbia University Mailman School of Public Health, and Jessica Justman, MD, ICAP's senior technical director, and associate professor of epidemiology, urge a coordinated global effort in the face of the COVID-19 pandemic, with "countries around the world [taking] concrete steps to assist Africa in staying ahead of the curve, even as they confront their own epidemics."

Released: 7-Apr-2020 9:50 AM EDT
Depressive Disorders Are ‘Under Recognized and Under Treated’ in People with HIV/AIDS
Wolters Kluwer Health: Lippincott Williams and Wilkins

People living with HIV/AIDS are at increased risk of depressive disorders. But all too often, these conditions go unrecognized or untreated, suggests a literature review in the May/June issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Rachel Vreeman Appointed Chair of Global Health and Director of the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai
Released: 11-Mar-2020 10:30 AM EDT
Rachel Vreeman Appointed Chair of Global Health and Director of the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai
Mount Sinai Health System

Appointment Enhances Efforts by the Institute to Improve Health of Communities Locally and Internationally

Newswise: Curcumin is the spice of life when delivered via tiny nanoparticles
Released: 5-Mar-2020 8:05 AM EST
Curcumin is the spice of life when delivered via tiny nanoparticles
University of South Australia

For years, curry lovers have sworn by the anti-inflammatory properties of turmeric, but its active compound, curcumin, has long frustrated scientists hoping to validate these claims with clinical studies.

3-Mar-2020 3:50 PM EST
Shedding light on hidden HIV
Universite de Montreal

Initiating antiretroviral therapy at a very early stage makes HIV reservoirs shrink by 100 times, researchers in Canada, the U.S. and Thailand find.

Released: 26-Feb-2020 10:05 AM EST
Patients Better Informed About Health After HIV And HCV Tests That Give Immediate Results
Johns Hopkins University Carey Business School

When substance use disorder patients were tested for both HIV and hepatitis C virus at the same time and given the results within 20 minutes, they were far more likely a month later to indicate they had received results, compared with patients who were referred for testing services.

Newswise: Scientists receive NIH grant to support study using THC as therapy for HIV patients suffering from inflammation
Released: 26-Feb-2020 9:00 AM EST
Scientists receive NIH grant to support study using THC as therapy for HIV patients suffering from inflammation
Texas Biomedical Research Institute

More than $3.7 million was awarded to Mahesh Mohan, DVM, MS, Ph.D., Professor at the Texas Biomedical Research Institute, and Chioma M. Okeoma, Ph.D., Associate Professor at Stony Brook University, to explore the link between cannabinoids (THC) and chronic intestinal inflammation in patients infected with the human immunodeficiency virus (HIV).

Newswise: New clues emerge on how to block reemergence of HIV
Released: 12-Feb-2020 2:45 PM EST
New clues emerge on how to block reemergence of HIV
University of Washington School of Medicine

“We wanted to answer the question ‘How does HIV bounce back when treatment is stopped?'" said Dr. Florian Hladik.

Newswise: José A. Bauermeister, PhD, Appointed Chair of Penn Nursing’s Department of Family and Community Health
Released: 10-Feb-2020 11:10 AM EST
José A. Bauermeister, PhD, Appointed Chair of Penn Nursing’s Department of Family and Community Health
University of Pennsylvania School of Nursing

José A. Bauermeister, PhD, MPH, Presidential Professor of Nursing, will be the next Chair of the University of Pennsylvania School of Nursing’s (Penn Nursing) Department of Family and Community Health, effective July 1, 2020.

Released: 10-Feb-2020 9:00 AM EST
Study Finds Innate Protein that Restricts HIV Replication by Targeting Lipid Rafts
George Washington University

A recent study from the George Washington University suggests that the innate protein AIBP restricts HIV-1 replications by targeting the lipid rafts the virus relies on.

Released: 6-Feb-2020 5:05 AM EST
Study Uses Powerful Sequencing Technology to Study HIV Epidemic in Washington, DC
George Washington University

Despite significant progress against HIV/AIDS, the nation’s capital is still battling an HIV epidemic with rates that are five times higher than the national average. A study published today in the journal Scientific Reports uses powerful next-generation sequencing technology to learn more about how the virus is spreading and developing drug resistance in the District of Columbia.

Released: 3-Feb-2020 7:05 PM EST
Tip Sheet: Tracking coronavirus, improving immunotherapies, cancer death rates decline, AAAS meeting and more
Fred Hutchinson Cancer Research Center

Summaries of recent Fred Hutch research studies, plus information on a press event at the upcoming AAAS annual meeting in Seattle.

31-Jan-2020 11:55 AM EST
HIV antibody therapy is associated with enhanced immune responses in infected individuals
Universite de Montreal

In a study in Nature Medicine, researchers describe how injection of neutralizing antibodies are associated with enhanced T cell responses that specifically recognize HIV.

Newswise: A Brain Link to STI/HIV Sexual Risk: Young women with Low Condom Use During Sex Find Visual Sexual Cues Less Pleasant and Less Evocative
Released: 27-Jan-2020 2:30 PM EST
A Brain Link to STI/HIV Sexual Risk: Young women with Low Condom Use During Sex Find Visual Sexual Cues Less Pleasant and Less Evocative
University of Pennsylvania School of Nursing

Data show that young adult women in the United States have high rates of sexually transmitted infections (STIs) that increase their risk of HIV. Though epidemiologic and behavioral factors for risk have been studied, we know very little about brain factors that may be linked to STI/ HIV sexual risk.

21-Jan-2020 11:10 AM EST
Researchers Reverse HIV Latency, Important Scientific Step Toward Cure
University of North Carolina School of Medicine

Overcoming HIV latency – activating HIV in CD4+ T cells that lay dormant – is a needed step toward a cure. Scientists at UNC-Chapel Hill, Emory University, and Qura Therapeutics – a partnership between UNC and ViiV Healthcare – showed it’s possible to drive HIV out of latency in two animal models.

Newswise: Blood Stem Cell Research
Released: 15-Jan-2020 2:05 PM EST
Blood Stem Cell Research
University of Delaware

A nanoparticle carrier system that could eliminate the need for bone marrow transplants, which are both expensive and difficult for patients to undergo. The University of Delaware's Emily Day, an assistant professor of biomedical engineering, is developing a platform that could treat stem cells directly without the need to remove them from the body.

Newswise: Suo_photo.jpg
Released: 8-Jan-2020 4:15 PM EST
FSU study aids fight against HIV, hepatitis B
Florida State University

A discovery by Florida State University College of Medicine researchers is expected to open the door for new and more potent treatment options for many of the more than 36 million people worldwide infected with the HIV virus and for others chronically ill with hepatitis B.

Released: 7-Jan-2020 5:45 PM EST
Intervention for patients hospitalized with HIV improved reengagement and outcomes of care
UT Southwestern Medical Center

Providing multidisciplinary team consults for HIV patients while they are hospitalized to help address social and medical barriers reduces future infection rates and boosts participation in follow-up care, results from a study on how to reengage patients show.

Newswise: Women with single dose of HPV vaccine gain similar protection as multiple doses
20-Dec-2019 1:10 PM EST
Women with single dose of HPV vaccine gain similar protection as multiple doses
University of Texas Health Science Center at Houston

A new study revealed that one dose of the HPV vaccine may prevent infection from the potential cancer-causing virus, according to research published in JAMA Network Open from The University of Texas Health Science Center at Houston (UTHealth).

Released: 26-Dec-2019 2:35 PM EST
Managing HIV/HCV Drug Interactions – JANAC Presents an Update for Nurses
Wolters Kluwer Health: Lippincott Williams and Wilkins

New direct-acting antiviral (DAA) medications are highly effective in curing patients with hepatitis C virus (HCV). But these drugs carry a risk of interactions with antiretroviral therapy (ART) used to control HIV. An update on management of drug interactions in patients coinfected with HIV/HCV is presented in The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

Released: 20-Dec-2019 4:45 PM EST
New study shows pregnant women with HIV often not given recommended treatment
Ann and Robert H. Lurie Children's Hospital of Chicago

Pregnant women living with HIV don’t always receive antiretroviral medications recommended for use in pregnancy, according to a recent study published in Jama Network Open this week. Ann & Robert H. Lurie Children's Hospital of Chicago’s researchers collaborated in the multi-site Surveillance Monitoring for ART Toxicities (SMARTT) study of the Pediatric HIV/AIDS Cohort Study (PHACS) network.

Released: 19-Dec-2019 2:45 PM EST
FY 2020 Spending Bill Funds Critical Initiatives While Neglecting Urgent Priorities
Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA)

The spending bill passed today is a welcome step forward. Allocations in the bill will strengthen public health and research efforts during the year ahead and will provide critical support for important goals. At the same time, the legislation in its final form also brings inadequate responses to current and urgent challenges with the potential for long-term and costly consequences.

Newswise: A Decade in Review: 7 Healthcare Breakthroughs
Released: 18-Dec-2019 3:50 PM EST
A Decade in Review: 7 Healthcare Breakthroughs
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health experts weigh in on the most significant healthcare advances of the last ten years and what exciting developments we can look forward to in the decade ahead.

Released: 16-Dec-2019 11:05 AM EST
Novel drug purified and developed from Amazon rainforest tree sap being studied for treatment of chronic diarrhea
University of Texas Health Science Center at Houston

A drug purified and developed from the sap of a tree in the Amazon rainforest is now being studied for the treatment of chronic idiopathic diarrhea in non-HIV patients at The University of Texas Health Science Center at Houston (UTHealth) as part of a two-year pilot study.

16-Dec-2019 3:05 AM EST
Young adults experiencing homelessness are not seeking medical care after rape
University of Texas Health Science Center at Houston

Nearly three-fourths of young adults experiencing homelessness who are raped do not seek post-sexual assault medical care, missing an opportunity to greatly reduce their risk of contracting HIV, according to a survey led by The University of Texas Health Science Center at Houston (UTHealth).

Released: 12-Dec-2019 3:30 PM EST
House Drug Pricing Bill Serves Patients, Public Health
Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA)

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies for conditions including HIV and hepatitis C. Importantly, the legislation also brings essential resources to combat antibiotic resistance, find and develop new infection fighting drugs and bring them to market. The balanced approach of this legislation will serve patients and public health.

Released: 6-Dec-2019 3:05 PM EST
Current treatment for fungal meningitis is fueling drug resistance
University of Liverpool

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

Newswise: New prevention program uses emergency room to reach black women at risk for HIV
Released: 3-Dec-2019 12:35 PM EST
New prevention program uses emergency room to reach black women at risk for HIV
University of Texas Health Science Center at Houston

With a disproportionate number of black cisgender women in the U.S. becoming HIV positive, researchers are sharing critical health information through an atypical venue: the emergency room.

Released: 2-Dec-2019 12:40 PM EST
This World AIDS Day Finds Us at a Crossroads
Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA)

This World AIDS Day marks a promising and unprecedented point in a quest begun nearly four decades ago to end the global public health threat of HIV through science and solidarity. Increasingly, effective and essential technologies, medicines and measures to effectively treat the virus and prevent transmissions are finding their way to where they are needed most and are demonstrating that we have what is needed to end this pandemic. For the first time, the United States has developed a plan aiming to end the American epidemic. And in keeping with hard-earned knowledge as well as with the theme of this World AIDS Day, communities are at the center of ambitious responses. Still, this World AIDS Day finds progress stalled by policies and politics that threaten the momentum we have gathered.

Newswise: To Meet HIV World Health Goals, TB Must Also Be Reduced
Released: 26-Nov-2019 4:00 PM EST
To Meet HIV World Health Goals, TB Must Also Be Reduced
American Thoracic Society (ATS)

The World Health Organization has set a goal of ending the AIDS epidemic by 2030.

26-Nov-2019 9:00 AM EST
HIV: Overwhelming the enemy from the start
Universite de Montreal

Virologist Eric Cohen and his team have identified a way to thwart HIV infection at its very early stages.

Newswise: Johns Hopkins Experts Available in Observance of World AIDS Day
Released: 26-Nov-2019 8:00 AM EST
Johns Hopkins Experts Available in Observance of World AIDS Day
Johns Hopkins Medicine

Nearly 40 million people around the world are living with HIV, and experts believe about 20% do not know their status. In the U.S., more than 1 million people in the U.S. are living with HIV.

Newswise: Wound healing in mucous tissues could ward off AIDS
Released: 22-Nov-2019 4:05 AM EST
Wound healing in mucous tissues could ward off AIDS
University of Washington

Some primates can carry SIV, a virus resembling HIV, lifelong and yet not develop AIDS. They are able to repair SIV damage to intestinal mucous tissues and avoid escape of gut bacteria and other events leading to immune system exhaustion. The findings offer clues for new HIV treatments

Newswise: Philadelphia Foundation Grants $100,000 To Penn Nursing From Robert I. Jacobs Fund for HIV Prevention Study
Released: 20-Nov-2019 10:25 AM EST
Philadelphia Foundation Grants $100,000 To Penn Nursing From Robert I. Jacobs Fund for HIV Prevention Study
University of Pennsylvania School of Nursing

Penn Nursing has received a $100,000 grant from the Robert I. Jacobs Fund of the Philadelphia Foundation for HIV research. The grant supports an investigation, “Youth-driven Perspectives in HIV Biomedical Prevention and Cure Research,” led by José A. Bauermeister, PhD, MPH, Presidential Professor of Nursing.

Newswise: Mapping the pathway to gut health in HIV patients
Released: 19-Nov-2019 2:00 PM EST
Mapping the pathway to gut health in HIV patients
UC Davis Health

A UC Davis study found that Lactobacillus plantarum bacteria rapidly repaired damaged gut lining (known as leaky gut) in monkeys infected with chronic simian immunodeficiency virus (SIV), an HIV-like virus. It linked chronically inflamed leaky gut to the loss of PPARα signaling and damage to mitochondria.

Newswise: Anal cancer rates and mortality have risen dramatically among Americans
18-Nov-2019 12:20 PM EST
Anal cancer rates and mortality have risen dramatically among Americans
University of Texas Health Science Center at Houston

Rates of new anal cancer diagnoses and deaths related to human papillomavirus (HPV), the most common sexually transmitted infection, have increased dramatically over the last 15 years, according to researchers at The University of Texas Health Science Center at Houston (UTHealth). The results of their study will be published in the November issue of the Journal of the National Cancer Institute.

13-Nov-2019 5:05 PM EST
The Invisible US Hispanic/Latino HIV Crisis: Addressing Gaps in the National Response
New York University

American Journal of Public Health article sees heightened dangers for Hispanics/Latinos, and an urgent need for enhanced public-health response.


Showing results

150 of 1403

close
0.84609